Literature DB >> 26077133

Change in vital signs after fingolimod initiation in patients with multiple sclerosis: the possible need for 24 h monitoring.

Uchida Tomohiko1, Masahiro Mori1, Uzawa Akiyuki1, Saeko Masuda1, Mayumi Mutho1, Hiroki Masuda1, Satoshi Kuwabara1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26077133      PMCID： PMC4574845          DOI： 10.1111/bcp.12697

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects.

Authors:  John M Kovarik; Robert Schmouder; Denise Barilla; Yibin Wang; Gerolf Kraus
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  Delayed fingolimod-associated asystole.

Authors:  Patricio S Espinosa; Joseph R Berger
Journal:  Mult Scler       Date:  2011-06-07       Impact factor: 6.312

Review 3.  Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.

Authors:  Jeffrey A Cohen; Jerold Chun
Journal:  Ann Neurol       Date:  2011-05       Impact factor: 10.422
  3 in total
  1 in total

1.  Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study.

Authors:  Rozita Doosti; Abdorreza Naser Moghadasi; Amir Reza Azimi; Shahrokh Karbalai Saleh; Masoud Etemadifar; Vahid Shaygannejad; Fereshteh Ashtari; Mohammad Hossein Harirchian; Seyed Bahaadin Siroos; Hormoz Ayramloo; Nastaran Majdinasab; Seyyed Mohammad Masood Hojjati; Nabiollah Asghari; Seyed Mohammad Baghbanian; Hamed Cheraghmakani; Mahmoud Abedini; Behnaz Sedighi; Negar Mohseni Abbas Abadi; Maedeh Ghasemitabar; Sara Talebianpour; Tohid Babayi Daylari; Vahid Dana; Neda Ghaleh Noie; Mohammad Ali Sahraian
Journal:  Caspian J Intern Med       Date:  2021-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.